Subscribe Today

Get our free articles delivered directly to your email!

RA CAPITAL MANAGEMENT, L.P.

AUM: $11.32 B

13-F Portfolio Value: $9.44 B

Last 13-F Filed: Q1 2026

Concentration in top 10: 61.29%

Stock	Company	% Portfolio	Shares Held	Market Value	Change in Shares	% Change	Quarter End Price	Source
FDMT	4D MOLECULAR THERAPEUTICS IN	0.39%	5,049,779	$47,013,442	-603,432	-10.67%	$9.31	13F
VOR	Vor Biopharma Inc.	0.31%	2,402,095	$37,881,038	-3,002,903	-55.56%		Form 4
CTNM	CONTINEUM THERAPEUTICS INC-A	0.14%	1,296,012	$16,925,917	-883,699	-40.54%	$13.06	13F
HOWL	WEREWOLF THERAPEUTICS, INC.	0.00734%	1,985,541	$714,795	-4,695,766	-70.28%		13D